Adamantiadi-Behçet syndrome: Treatment with synthetic leukocytic interferon

Terapevticheskii Arkhiv

Volumn 73, Issue 5, 2001, Pages 43-45

  Kacunaros, M ^a   Alicanidu, O ^a   Balacucas, D ^a   Agapakis, D ^a   Palyaleksis, K ^a   Karali, V ^a   Kukurikos, S ^a  

^a NONE

Author keywords

Adamantiadi Behcet syndrome; Interferon; Treatment

Indexed keywords

ANTIVIRUS AGENT; RECOMBINANT INTERFERON;

ADULT; ARTICLE; BEHCET DISEASE; FEMALE; FOLLOW UP; HUMAN; MALE; TIME;

ADULT; ANTIVIRAL AGENTS; BEHCET SYNDROME; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON TYPE I, RECOMBINANT; MALE; TIME FACTORS;

EID: 0035236078     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Goolamill S. K., Comaish J. S., Hassanyer F., Stephens A. Familial Behcet syndrome. Br. J. Dermatol. 1976; 95: 637-642.
2. Michelson J. B., Chisari E. V. Behcet's disease. Surv. Ophthalmol. 1982; 26: 190-203.
3. Tsambaos D., Eichelberg, Goos M. Behcet syndrome: Treatment with recombinant leukocyte alpha-interferon. Dermatol. Res. 1986; 278: 335-336.
4. Ohno S., Kato F., Matsuda H. et al. Detection of gamma Interferon in the sera of patients with Behcet's disease. Infect, and Immun. 1982; 36: 202-208.
5. Serdanoglu P., Yazici H., Ozdenir C. et al. Neurologic involvement in Behcet's syndrome: a prospective study. Arch. Neurol. (Chic.). 1989; 46: 265-269.
6. Herskovitz S., Lipton R. B., Lantos G. Neuro-Behcet's disease: CT and clinical correlates. Neurology. 1988; 38: 1714-1720.
7. Amrom D., Buisseret T. Clinical radiological correlation in the evolution of a neuro-Behcet's syndrome: case report. Eur. Neurol. 1991: 419-422.